Diabetes in pregnancy (DIP) is one of the most common pregnancy-specific health challenges. Globally, the prevalence of diabetes in pregnancy among women aged 20–49 years was estimated to be 17% affecting 21.4 million live births with more than 90% cases occurring in low- and middle-income countries. Let’s hear from our experts Dr M P Baruah, Dr Beena Bansal, Dr Girish Parmar on therapeutic advances in diabetes in pregnancy, the concepts and issues surrounding it, as well as it's management, in this informative webinar presented by Novo Nordisk.

Therapeutic Advances in DIP

Founder & Director, Door to Care, Gurgaon

Dr. Beena Bansal

1

1.2k

24.6k

4.6

Sessions Taken

1.5k

4.6